Table 2.
Serum lipid responses to 16 weeks of aerobic exercise in stage 3 CKD patients
| EX |
CON |
|||||
|---|---|---|---|---|---|---|
| Lipid variable, mmol/L (mg/dL) | Baseline | 16 weeks | Baseline | 16 weeks | Adjusted mean difference (95% CI)a | P-valueb |
| Total cholesterol | 4.95 ± 1.18 | 4.89 ± 1.01 | 4.49 ± 0.91 | 4.12 ± 0.92 | 0.44 (−0.001, 0.88) | 0.051 |
| (191.43 ± 41.54) | (189.04 ± 38.91) | (173.59 ± 35.31) | (159.35 ± 35.73) | [16.92 (−0.05, 33.89)] | ||
| HDL | 1.18 ± 0.38 | 1.15 ± 0.39 | 1.34 ± 0.57 | 1.26 ± 0.67 | 0.04 (−0.14, 0.22) | 0.64 |
| (45.74 ± 14.51) | (44.61 ± 14.29) | (51.94 ± 21.99) | (48.82 ± 25.77) | [1.62 (−5.36, 8.60)] | ||
| LDL | 2.93 ± 0.94 | 2.98 ± 0.99 | 2.51 ± 0.57 | 2.27 ± 0.79 | 0.45 (−0.04, 0.94) | 0.07 |
| (113.26 ± 36.27) | (115.13 ± 38.36) | (97.23 ± 31.42) | (87.70 ± 30.60) | [17.38 (−1.51, 36.28)] | ||
| TGs | 1.83 ± 0.81 | 1.83 ± 0.93 | 1.30 ± 0.68 | 1.41 ± 0.80 | 0.003 (−0.45, 0.46) | 0.99 |
| (162.22 ± 71.91) | (161.69 ± 81.96) | (114.76 ± 59.80) | (125.11 ± 70.65) | [0.29 (−40.15, 40.74)] | ||
Values are mean ± standard deviation.
a
95% confidence interval (CI) for the difference between adjusted means of EX and CON at 16 weeks, controlling for baseline assessment.
b
P-value for difference between EX and CON at 16 weeks analyzed by a one-way ANCOVA.